Key result
Statin use was associated with decreased long-term mortality in patients with abdominal aortic aneurysm, but not in those with thoracic aortic aneurysm.
Why the study?
Does statin use reduce long-term mortality in patients with abdominal or thoracic aortic aneurysm undergoing elective endovascular repair?
Cohort (n=790)
Does statin use reduce long-term mortality in patients with abdominal or thoracic aortic aneurysm undergoing elective endovascular repair?
Statin use is associated with improved long-term survival after elective endovascular repair in patients with abdominal, but not thoracic, aortic aneurysms.
Answers are grounded in this paper and cite their sources.
Supports statin consideration post-EVAR in AAA but not TAA; hypothesis-generating and requires RCTs before practice change.
BACKGROUND: Purpose of this study was to compare the correlation of statin use with long-term mortality in patients with abdominal (AAA) and thoracic aortic aneurysm (TAA). PATIENTS AND METHODS: We compared long-term survival of 731 AAA and 59 TAA patients undergoing elective endovascular repair (EVAR). Kaplan-Meier survival curves were compared by the log-rank method. Propensity score-adjusted multivariable logistic regression models were used to determine independent associations of statin use on vital status after EVAR. RESULTS: Statin use was associated with decreased long-term mortality in AAA patients in bivariate and multivariable regression analysis, in which the effect of propensity to receive a statin was considered (adjusted HR: .613, 95%-CI: .379- .993, p = .047) whereas mortality of TAA patients was not associated with use of statins (adjusted HR: 1.795, 95%-CI: .147 -21.942, p = .647). CONCLUSIONS: Use of statins is an independent predictor of decreased mortality after elective EVAR in AAA, but not in TAA patients. These findings indirectly support the concept of a distinct pathogenesis of AAA and TAA.
No takes yet. Share an insight, caveat, or question.
Diehm et al. (2008) conducted a cohort in Abdominal and thoracic aortic aneurysm (n=790). Statin use vs. No statin use was evaluated on Long-term mortality (HR 0.613, 95% CI 0.379-0.993, p=0.047). Statin use was associated with decreased long-term mortality in patients with abdominal aortic aneurysm, but not in those with thoracic aortic aneurysm.
Synapse has enriched 10 related papers. Consider them for comparative context: